159 related articles for article (PubMed ID: 27465903)
1. Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125.
Lee JY; Kim JH; Seo JW; Kim HS; Kim JW; Park NH; Song YS
Int J Gynecol Cancer; 2016 Oct; 26(8):1434-9. PubMed ID: 27465903
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
Bristow RE; Purinton SC; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL
Gynecol Oncol; 2006 Nov; 103(2):709-13. PubMed ID: 16797686
[TBL] [Abstract][Full Text] [Related]
3. Post treatment surveillance of type II endometrial cancer patients.
Zakhour M; Li AJ; Walsh CS; Cass I; Karlan BY; Rimel BJ
Gynecol Oncol; 2013 Dec; 131(3):609-12. PubMed ID: 24051222
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics of recurrent endometrioid endometrial cancer patients and analysis of methods used durıing surveillance.
Simsek SY; Serbetcioglu G; Alemdaroglu S; Yetkinel S; Durdag GD; Celik H
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):473-477. PubMed ID: 31212025
[TBL] [Abstract][Full Text] [Related]
5. Patterns and utility of routine surveillance in high grade endometrial cancer.
Hunn J; Tenney ME; Tergas AI; Bishop EA; Moore K; Watkin W; Kirschner C; Hurteau J; Rodriguez GC; Lengyel E; Lee NK; Yamada SD
Gynecol Oncol; 2015 Jun; 137(3):485-9. PubMed ID: 25838164
[TBL] [Abstract][Full Text] [Related]
6. [Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
Wang Q; Hong L; Wang JL; Yue MG; Li HB; Li Y
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):300-3. PubMed ID: 20510085
[TBL] [Abstract][Full Text] [Related]
7. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
8. Recurrence patterns and surveillance for patients with early stage endometrial cancer.
Salani R; Nagel CI; Drennen E; Bristow RE
Gynecol Oncol; 2011 Nov; 123(2):205-7. PubMed ID: 21820709
[TBL] [Abstract][Full Text] [Related]
9. Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma.
Steele E; Umar SA; Bomeisl P; Miedler J; Zanotti KM; Wasman JK; Hunt DC; Abdul-Karim FW
Diagn Cytopathol; 2012 Feb; 40(2):138-40. PubMed ID: 20891002
[TBL] [Abstract][Full Text] [Related]
10. Misleading CA-125 levels and computed tomography images in an endometrial cancer patient.
Tjalma WA
J Obstet Gynaecol; 2004 Jun; 24(4):470-1. PubMed ID: 15203605
[No Abstract] [Full Text] [Related]
11. The value of FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker.
Ozcan Kara P; Kara T; Kaya B; Kara Gedik G; Sari O
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):257-60. PubMed ID: 23067527
[TBL] [Abstract][Full Text] [Related]
12. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
[TBL] [Abstract][Full Text] [Related]
13. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer.
Kiran G; Kesterson JP; Ozerkan K; Kanis M; Groman A; Lele S
Eur J Gynaecol Oncol; 2013; 34(6):522-6. PubMed ID: 24601043
[TBL] [Abstract][Full Text] [Related]
15. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
[TBL] [Abstract][Full Text] [Related]
16. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
17. The utility and management of vaginal cytology after treatment for endometrial cancer.
Novetsky AP; Kuroki LM; Massad LS; Hagemann AR; Thaker PH; Powell MA; Mutch DG; Zighelboim I
Obstet Gynecol; 2013 Jan; 121(1):129-35. PubMed ID: 23262937
[TBL] [Abstract][Full Text] [Related]
18. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
[TBL] [Abstract][Full Text] [Related]
19. Vaginal Cytology Results in Follow-up of Endometrial Carcinoma After Hysterectomy.
Zhao C; Karunamurthy A; Jain S; Austin RM
Am J Clin Pathol; 2016 Aug; 146(2):244-7. PubMed ID: 27371362
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
Bhosale P; Peungjesada S; Wei W; Levenback CF; Schmeler K; Rohren E; Macapinlac HA; Iyer RB
Int J Gynecol Cancer; 2010 Aug; 20(6):936-44. PubMed ID: 20683399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
